Clinical Trial

A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 24, 2023 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This research will admit a wide range of data on the clinical study experience of metastatic prostate cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with metastatic prostate cancer.
Trial Details
NCT Number NCT06009549
Lead Sponsor Power Life Sciences Inc.
Conditions Metastatic Prostate Cancer
Enrollment 500 participants
Start Date 2024-09
Primary Completion 2025-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2023-08-24